Literature DB >> 16499830

Intravenous treatment of chronic daily headaches in the outpatient headache clinic.

John Claude Krusz1.   

Abstract

The most likely future of aggressive headache treatment will reside in the sphere of the specialist's clinic. This is a far more cost- and time-effective mode of treating intractable chronic daily headaches (CDH), including chronic migraines. We have used this technique successfully in our clinic for many years. Our experience with intravenous treatment of headaches and migraines was summarized recently and a 97.5% success rate for this type of treatment was found in the clinic. Compared with the treatments commonly available in the emergency department, the specialist's clinic can offer more effective headache-altering definitive treatments. Patients can be offered a maximum degree of success for control of their intractable headaches. In this article, approaches to aggressive treatment of ongoing CDH using intravenous methods of therapy are discussed. All of these can be performed in the clinic setting, avoiding some of the costly aspects of treatment that are present in an emergency room setting.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16499830     DOI: 10.1007/s11916-006-0009-z

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  39 in total

Review 1.  Prophylaxis for chronic daily headache and chronic migraine with neuronal stabilizing agents.

Authors:  John Claude Krusz
Journal:  Curr Pain Headache Rep       Date:  2002-12

2.  Efficacy of sustained-release bupropion in neuropathic pain: an open-label study.

Authors:  M R Semenchuk; B Davis
Journal:  Clin J Pain       Date:  2000-03       Impact factor: 3.442

3.  A comparative trial of three agents in the treatment of acute migraine headache.

Authors:  R Bell; D Montoya; A Shuaib; M A Lee
Journal:  Ann Emerg Med       Date:  1990-10       Impact factor: 5.721

4.  Droperidol treatment of status migrainosus and refractory migraine.

Authors:  S J Wang; S D Silberstein; W B Young
Journal:  Headache       Date:  1997-06       Impact factor: 5.887

5.  Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system.

Authors:  M A King; S Bradshaw; A H Chang; J E Pintar; G W Pasternak
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

6.  Treatment of primary headache disorders with intravenous valproate: initial outpatient experience.

Authors:  Mark J Stillman; Deborah Zajac; Lisa A Rybicki
Journal:  Headache       Date:  2004-01       Impact factor: 5.887

7.  Cerebrospinal fluid glutamate levels in chronic migraine.

Authors:  M F P Peres; E Zukerman; C A Senne Soares; E O Alonso; B F C Santos; M H W Faulhaber
Journal:  Cephalalgia       Date:  2004-09       Impact factor: 6.292

8.  Exploration of NMDA receptors in migraine: therapeutic and theoretic implications.

Authors:  M Nicolodi; F Sicuteri
Journal:  Int J Clin Pharmacol Res       Date:  1995

9.  Abortive migraine therapy in the office with dexamethasone and prochlorperazine.

Authors:  H A Saadah
Journal:  Headache       Date:  1994-06       Impact factor: 5.887

10.  Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine.

Authors:  E R Scherl; J F Wilson
Journal:  Headache       Date:  1995-05       Impact factor: 5.887

View more
  3 in total

Review 1.  Chronic Daily Headache: Mechanisms and Principles of Management.

Authors:  Amy W Voigt; Harry J Gould
Journal:  Curr Pain Headache Rep       Date:  2016-02

2.  Refining clinical features and therapeutic options of new daily persistent headache: a retrospective study of 63 patients in India.

Authors:  Sanjay Prakash; Samir Saini; Kaushikkumar Ramanlal Rana; Pinaki Mahato
Journal:  J Headache Pain       Date:  2012-05-27       Impact factor: 7.277

Review 3.  Lidocaine and pain management in the emergency department: a review article.

Authors:  Samad Ej Golzari; Hassan Soleimanpour; Ata Mahmoodpoor; Saeid Safari; Alireza Ala
Journal:  Anesth Pain Med       Date:  2014-02-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.